ABSTRACT
The Bolivia study is part of an ongoing multiple case study organized by the FAO's Regional Office for Latin America and the Caribbean as part of the activities of the Technical Cooperation Network on Agricultural Biotechnology (REDBIO/FAO). The basic information was obtained through a survey and/or direct interview to a significant number of experts from Bolivian institutions involving management, regulation, research, innovation, application and education of agricultural biotechnology. At national level, the most relevant applied agri-biotechnologies are presently in vitro plant culture, genomics, molecular genetics, assisted reproduction techniques in animals, and techniques supporting plant and animal disease diagnosis. They have been developed and appropriated to support the agricultural sector including genetically modified crops. Over the past ten years, the public research and academic institutions have allocated resources to implement laboratories and others have widened and updated their facilities. Nonetheless, a different situation is observed in the private sector where some laboratories have been forced to close down and to reduce production due to the economic crisis of the country. In view of the country's specific needs and opportunities regarding conservation and utilization of genetic resources, biotechnology can constitute a valuable tool for the sustainable development of the country.
Subject(s)
Agriculture , Biotechnology , Public Policy , Bolivia , Developing CountriesABSTRACT
La EBOC y la insuficiencia respiratoria crónica constituyen un problema importante de Salud Pública. Ha sido demostrado que la oxigenoterapia continua, mejora tanto la sobrevida como la calidad de vida de estos pacientes. Por esta razón, a partir de 1984 se inició la organización e implementación de un Programa de Oxigenoterapia (OD), dependiente del Servicio de Medicina del INERCYCT, que al momento actual dispone de una estructura operacionalmente eficiente. Los criterios de selección para ingresar pacientes al programa fueron: PaO2 <55 mmHg y ausencia de patología asociada grave y de hábitos nocivos. Se han evaluado 47 pacientes portadores de EBOC, de los cuales 16 fueron ingresados al estudio. Seis meses Post OD, observamos, disminución tanto de la frecuencia de hospitalizaciones como del número de días/cama, no observándose cambios en las espirometrías, PaO2, PaCO2 y ECG. Sin embargo, encontramos mejoría en la calidad de vida, objetivada a través de una entrevista psiquiátrica, lo cual a la luz de estudios previos, se podría atribuir a la oxigenoterapia aportada